Changes in glucose concentration during refrigerated storage of caprine platelet-rich plasma: A reliable biochemical marker of platelet storage lesions
Abstract
Platelet-rich plasma (PRP) is increasingly used in regenerative medicine because of its high concentration of platelets and growth factors. However, platelets remain metabolically active during storage and undergo progressive biochemical deterioration known as platelet storage lesions (PSL). The present study evaluated changes in glucose concentration in caprine PRP stored at 4°C for seven days. Blood samples collected from eight (n = 8) clinically healthy goats were processed using a double centrifugation technique to obtain PRP. Platelet additive solution was incorporated before storage, and glucose concentration was estimated at predetermined intervals using the glucose oxidase-peroxidase (GOD-POD) method. A progressive decline in glucose concentration was observed throughout the storage period, decreasing from 3.23 ± 0.33 mmol/L at 0 h to 0.54 ± 0.05 mmol/L on Day 7. The findings indicate continuous glycolytic activity despite refrigerated storage and demonstrate that glucose depletion is an early biochemical marker of platelet storage lesions. Monitoring glucose concentration may therefore serve as a useful quality indicator for stored caprine PRP intended for regenerative applications.
Full Text
Tables and figures are in the full-text PDF.
Introduction
Platelets are small, anucleate cytoplasmic fragments derived from bone marrow megakaryocytes that play an essential role in haemostasis, thrombosis, inflammation and tissue repair. Beyond their traditional role in blood coagulation, platelets have gained considerable attention in regenerative medicine because they contain numerous biologically active growth factors capable of stimulating cellular proliferation, angiogenesis and extracellular matrix synthesis (Aibibula et al., 2018) [1] . These properties have led to the widespread use of plateletrich plasma (PRP) in both human and veterinary medicine for the treatment of musculoskeletal injuries, chronic wounds, tendon disorders, osteoarthritis and various orthopedic conditions. Platelet-rich plasma is prepared by concentrating platelets from autologous whole blood through differential centrifugation. Compared with whole blood, PRP contains several-fold higher platelet concentrations along with platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF) and insulin-like growth factor-1 (IGF-1) (Aibibula et al., 2018) [1] . These bioactive molecules accelerate tissue repair by promoting fibroblast proliferation, collagen synthesis, angiogenesis and modulation of inflammatory responses. Consequently, PRP has emerged as a valuable biological therapeutic agent in regenerative medicine. Although PRP is preferably used immediately after preparation, storage becomes inevitable in clinical practice, research laboratories and blood banking. During storage, platelets continue to remain metabolically active despite being outside the physiological environment. Ongoing cellular metabolism gradually induces structural, biochemical and functional alterations collectively known as platelet storage lesions (PSL) (Bruns & Knowler, 2009) [2] .
These alterations include glucose depletion, lactate accumulation, reduction in pH, oxidative stress, membrane damage, potassium leakage, enzyme alterations and diminished platelet functionality. Among these biochemical changes, glucose depletion is one of the earliest and most reliable indicators of platelet metabolic activity during storage. Platelets utilize glucose as their principal energy substrate through glycolysis and oxidative phosphorylation to generate adenosine triphosphate (ATP), which is essential for maintaining membrane integrity, cytoskeletal organization, ion transport and platelet activation (Aibibula et al., 2018) [1] . As storage duration increases, platelets increasingly depend on anaerobic glycolysis, resulting in progressive glucose consumption and lactate accumulation. These metabolic alterations eventually compromise platelet viability and therapeutic efficacy. Several studies have reported that glucose concentration decreases progressively during storage of blood and platelet products. Sacks [6,3,2,4,5] . Despite increasing applications of PRP in veterinary regenerative medicine, limited information is available regarding glucose metabolism in stored caprine PRP. Understanding glucose utilization during storage is essential for determining the biochemical stability and quality of platelet concentrates intended for therapeutic use. Therefore, the present study was undertaken to evaluate changes in glucose concentration during refrigerated storage of caprine platelet-rich plasma and to determine its usefulness as an indicator of platelet storage lesions.
Materials and Methods
Ethical approval
The present investigation was carried out after obtaining approval from the Institutional Animal Ethics Committee of the Veterinary College and Research Institute, Tirunelveli. Experimental procedures were performed in accordance with CPCSEA guidelines governing the use of animals for research.
Experimental animals
Eight apparently healthy adult goats of either sex maintained at the District Livestock Farm, Abishekapatti, Tirunelveli and Livestock Farm Complex, Veterinary College and Research Institute, Tirunelveli, were selected for the study. Animals were clinically examined before blood collection to ensure normal physiological status.
Collection of blood samples
Approximately 8 mL of blood was collected aseptically from the jugular vein of each animal using sterile disposable syringes fitted with 20-gauge needles. Blood samples were immediately transferred into sterile centrifuge tubes containing Acid Citrate Dextrose (ACD) anticoagulant to prevent platelet activation and coagulation during processing.
Preparation of PRP
PRP was prepared by the double centrifugation protocol optimized in our lab. Initially, whole blood samples were centrifuged at 2500 rpm for 10 minutes to separate plasma and buffy coat from erythrocytes. The plasma layer containing buffy coat was carefully aspirated and subjected to a second centrifugation at 3500 rpm for 15 minutes. Following centrifugation, the upper platelet-poor plasma was discarded while the lower platelet-rich plasma fraction was retained. To improve platelet preservation during storage, Platelet Additive Solution (PAS) was incorporated into PRP at a ratio of 65% PAS and 35% PRP. Samples were gently mixed to avoid platelet activation before storage.
Storage and analysis of PRP
Prepared PRP samples were stored under refrigerated conditions at 4 °C for seven days. Glucose concentration was estimated immediately after PRP preparation (0 h), followed by analysis at 12 h, 24 h, 36 h, 48 h, Day 3, Day 5 and Day 7.
Glucose estimation
Glucose concentration was determined using the Glucose Oxidase-Peroxidase (GOD-POD) enzymatic colorimetric method employing a commercially available diagnostic kit (Delta Diagnostics, India). The principle of the assay is based on enzymatic oxidation of glucose by glucose oxidase to produce gluconic acid and hydrogen peroxide. In the presence of peroxidase, hydrogen peroxide reacts with phenol and 4aminoantipyrine to produce a pink-colored quinoneimine complex (Trinder, 1969) [7] . The intensity of the colour formed is directly proportional to glucose concentration and was measured at 505 nm using double beam uvvis spectrophotometer (UH 500 Hitachi, Japan) The glucose concentration was expressed in mmol/L
Statistical analysis
Data obtained at different storage intervals were expressed as Mean ± Standard Error (SE). Statistical analysis was performed using one-way analysis of variance (ANOVA). Differences among storage intervals were considered statistically significant at P < 0.05.
Results
Changes in glucose concentration during refrigerated storage of caprine PRP
Glucose concentration in caprine platelet-rich plasma declined progressively throughout the seven-day storage period under refrigerated conditions (4 °C). The mean glucose concentration at the time of preparation (0 h) was 3.23 ± 0.33 mmol/L, which gradually decreased to 2.84 ± 0.29 mmol/L after 12 h of storage. Further reductions were observed at 24 h (2.50 ± 0.25 mmol/L), 36 h (2.20 ± 0.20 mmol/L) and 48 h (1.94 ± 0.20 mmol/L). The decline became more pronounced during prolonged storage, with glucose concentration falling to 1.50 ± 0.15 mmol/L on Day 3, 0.90 ± 0.09 mmol/L on Day 5 and reaching the lowest value of 0.54 ± 0.05 mmol/L by Day 7. Statistical analysis revealed a significant (P < 0.05) decrease in glucose concentration with increasing storage duration. The overall reduction in glucose concentration from Day 0 to Day 7 was approximately 83.3%, indicating continuous metabolic activity of platelets despite refrigerated storage.
Discussion
Platelets remain metabolically active after collection and continue to consume glucose throughout storage to maintain intracellular ATP production (Aibibula et al., 2018) [1] . The present investigation demonstrated a continuous decline in glucose concentration in caprine platelet-rich plasma stored at 4°C, indicating sustained glycolytic metabolism even under refrigerated conditions. These findings suggest that refrigeration slows but does not completely inhibit platelet metabolism.
Glucose serves as the principal energy substrate for platelets and is essential for maintaining membrane integrity, ion transport, cytoskeletal rearrangement and activation responses. Platelets generate ATP through both oxidative phosphorylation and glycolysis (Aibibula et al., 2018) [1] . During storage, mitochondrial efficiency gradually decreases, causing platelets to increasingly rely on anaerobic glycolysis. Consequently, glucose is continuously consumed and converted into pyruvate, which is subsequently reduced to lactate. This metabolic shift explains the progressive decline in glucose concentration observed in the present study. The findings are also consistent with the observations of Bruns and Knowler, who emphasized that continued glycolysis is responsible for declining glucose concentrations in stored blood samples and that sodium fluoride alone is insufficient to completely inhibit glucose consumption immediately after collection. Their study highlighted the importance of rapid sample processing and appropriate storage conditions for preserving glucose stability.
Although previous studies largely investigated whole blood or plasma, similar metabolic principles apply to platelet-rich plasma because platelets retain active glycolytic enzymes throughout storage (Aibibula et al., 2018) [1] . [1] . Therefore, glucose depletion should not be considered an isolated metabolic event but rather an early indicator of a cascade of biochemical alterations associated with platelet storage lesions. Although refrigeration effectively slows cellular metabolism, the present findings demonstrate that significant glucose utilization continues even at 4 °C. This observation has practical implications for veterinary regenerative medicine. Platelet-rich plasma intended for therapeutic application should preferably be used as soon as possible after preparation to maximize platelet viability and preserve growth factor release. Extended refrigerated storage may reduce biological activity owing to progressive metabolic deterioration.
The findings of the present investigation therefore establish glucose estimation as a reliable biochemical marker for evaluating the metabolic status of stored caprine platelet-rich plasma. When interpreted together with lactate production, pH changes, oxidative stress markers and membrane integrity parameters, glucose concentration provides valuable information regarding platelet quality during storage.
Conclusion
The present study demonstrated a significant progressive decline in glucose concentration in caprine platelet-rich plasma during seven days of refrigerated storage. Continuous glucose depletion reflects persistent platelet metabolism despite storage at 4 °C and represents one of the earliest biochemical manifestations of platelet storage lesions. The marked reduction in glucose concentration after prolonged storage suggests increasing dependence on anaerobic glycolysis and declining platelet viability. Routine monitoring of glucose concentration may therefore serve as a simple, reliable and sensitive quality control parameter for evaluating stored platelet-rich plasma intended for regenerative medicine and transfusion applications. Further studies correlating glucose metabolism with platelet function and growth factor release will improve understanding of platelet storage biology and assist in optimizing storage protocols for veterinary use.
Acknowledgement
AcknowledgementsThe authors thank the Dean, Veterinary College and Research Institute, Tirunelveli, Tamil Nadu Veterinary and Animal Sciences University and the Director of Clinics for providing the necessary facilities to carry out this investigation. The authors also acknowledge the Deputy Director and other technical staff of the District Livestock Farm, Abishekapatti, and the Head of Department of Livestock Farm Complex, VCRI, Tirunelveli, for their assistance during sample collection. Funds for the study were available in the form of postgraduate grants to the department.
References
- Aibibula M, Naseem KM, Sturmey RG. Glucose metabolism and metabolic flexibility in blood platelets. Journal of Thrombosis and Haemostasis. 2018;16(11):2300-2314.
- Bruns DE, Knowler WC. Stabilization of glucose in blood samples: Why it matters. Clinical Chemistry. 2009;55(5):850-852.
- Chan AYW, Swaminathan R, Cockram CS. Stability of blood glucose at various temperatures: Implications for the pre-analytical phase. Annals of Clinical Biochemistry. 1995;32(3):288-292.
- Grzych G, Pekar JD, Maboudou P. Better glucose stability in serum than in plasma samples after 12-h stay at room temperature. Diabetes Technology & Therapeutics. 2019;21(7):413-414.
- Pleus S, Freckmann G, Baumstark A, Haug C. Stability of glucose concentrations in frozen plasma. Journal of Diabetes Science and Technology. 2022;16(5):10961100.
- Sacks DB, Bruns DE, Whitehurst JE, Keffer JH. Stability of plasma glucose in heparinized whole blood. Annals of Clinical Biochemistry. 1990;27(4):358-363.
- Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Annals of Clinical Biochemistry. 1969;6(1):24-27.
How this paper connects to the literature. Drag to explore, click any node to open that paper.
